Gerding, Hanne R.; Karreman, Christiaan; Daiber, Andreas et al.
Reductive modification of genetically encoded 3-nitrotyrosine sites in alpha synuclein expressed in E.coliREDOX BIOLOGY. Bd. 26. 2019
Tamburrini, Luca; Weisser, Gerhard; Espinola-Klein, Christine
Reentry devices for chronic arterial occlusionsVASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. Bd. 48. H. 5. 2019 S. 451-452
Panova-Noeva, Marina; Wagner, Bianca; Nagler, Markus et al.
Relation between platelet coagulant and vascular function, sex-specific analysis in adult survivors of childhood cancer compared to a population-based sampleSCIENTIFIC REPORTS. Bd. 9. 2019
Koriath, Moritz; Mueller, Christian; Pfeiffer, Norbert et al.
Relative Telomere Length and Cardiovascular Risk FactorsBIOMOLECULES. Bd. 9. H. 5. 2019
Eggebrecht, Lisa; Nagler, Markus; Goebel, Sebastian et al.
Relevance of Polypharmacy for Clinical Outcome in Patients Receiving Vitamin K AntagonistsJOURNAL OF THE AMERICAN GERIATRICS SOCIETY. Bd. 67. H. 3. 2019 S. 463-470
Arnold, N.; Hermanns, I. M.; Prochaska, J. H. et al.
RENIN, ALDOSTERONE, THE ALDOSTERONE-TO-RENIN RATIO AND INCIDENT ARTERIAL HYPERTENSION AMONG NORMOTENSIVE SUBJECTS FROM THE POPULATIONJOURNAL OF HYPERTENSION. Bd. 37. 2019 S. E47-E48
Li, Huige; Xia, Ning; Hasselwander, Solveig et al.
Resveratrol and Vascular FunctionINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 20. H. 9. 2019
Schuepke, Stefanie; Hein-Rothweiler, Ralph; Mayer, Katharina et al.
Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER TrialTHROMBOSIS AND HAEMOSTASIS. Bd. 119. H. 9. 2019 S. 1539-1545
Liebers, F; Jankowiak, S; Latza, U et al.
Risikofaktoren für Herz-Kreislauf-Erkrankungen bei Führungskräften - Deskreptive Auswertung der Baseline-Erhebung der Gutenberg-Gesundheitsstudie in MainzArbeitsmedizin Sozialmedizin Umweltmedizin. Bd. 54. H. 2. 2019 S. 106-115
Roe, Matthew T.; Li, Qian H.; Bhatt, Deepak L. et al.
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary SyndromesCIRCULATION. Bd. 140. H. 19. 2019 S. 1578-1589